Jayasree will speak on the panel “Innovating global health: Collaborative action where markets fail.”
This panel will discuss how new kinds of collaboration could bridge research, economic, and societal priorities to achieve a key societal mission: to strengthen health resilience. The COVID-19 pandemic has highlighted the importance of interdisciplinary and multisector collaboration to address unmet medical needs and emerging societal priorities. When markets and return of investment are limited, for example in novel antibiotics, pandemic vaccines, and some diagnostics, innovators find it difficult to secure funding, develop a sustainable pipeline, and to ensure financial returns. New business models are needed to strengthen health resilience.
Topics covered in this panel will include:
- How can collaborative partnerships and novel business models between governments, public research institutes, industry, funders and philanthropy help overcome economic barriers to sustainable health innovation where traditional markets do not deliver?
- How can these mechanisms become more anticipatory of resilience challenges?
In the session, Jayasree will discuss policy issues and collaborative strategies to deliver health products, such as antimicrobials, vaccines, diagnostics, etc. where markets and return of investment is limited. She will also delve into pharma efforts on R&D and access.
The panel will be moderated by Francesa Colombo, Head of the Health Division, Directorate for Employment, Labour and Social Affairs, OECD.
Other speakers on this panel include:
- Kevin Outterson, CARB-X
- Hani Kim, Executive Director, The Research Investment for Global Health Technology Fund (The RIGHT Fund)
- Pierre Meulien, Executive Director of the Innovative Medicines Initiative (IMI)
- Julie Gerberding, Executive Vice President and Chief Patient Officer, MSD
.png){kind=spacer}
